Triumph Capital Management »

Gt Biopharma shares owned by Triumph Capital Management

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by Triumph Capital Management from 13F filings

Historical chart of Triumph Capital Management investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Triumph Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Triumph Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.3k 1.7k 0.79

More positions owned by Triumph Capital Management

Apple (AAPL)
First Trust Enhanced Short Maturity Etf SHS (FTSM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
First Tr Exchange-traded Cap Strength Etf (FTCS)
First Tr Exchange-traded Smid Risng Etf (SDVY)
Ishares Tr Core S&p500 Etf (IVV)
Jpmorgan Ultra-short Income Etf SHS (JPST)
Dimensional Etf Trust Short Duration F (DFSD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
First Tr Exchange-traded SHS (FDL)
First Trust Low Duration Opportunities Etf SHS (LMBS)
Innovator Etfs Trust Quity Managd Flr (SFLR)

View all positions for Triumph Capital Management

Top funds holding Gt Biopharma

Scientech Research
SeaCrest Wealth Management
Citadel Advisors
Jane Street
Integrated Wealth Concepts
Geode Capital Management
Coston, McIsaac & Partners
Caitlin John
Wells Fargo & Company
HPM Partners
Am Investment Strategies
Verdence Capital Advisors
Two Sigma Securities
Prospera Financial Services
Hrt Financial

View all funds holding Gt Biopharma